111 HUNTINGTON AVENUE,
BOSTON , MA, 02199

Rank

Rank Universe

Summary

The fund seeks capital appreciation by investing in companies across any size outside the United States.

The investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.

Next, the research team focuses on foreign securities, including emerging market securities.

The team favors compani More

Link

Directors

Nov 12, 2021
  • Laurie J. Thomsen
  • Peter D. Jones
  • John P. Kavanaugh
  • Michael W. Roberge
  • Maryanne L. Roepke
  • Clarence Otis, Jr.
  • Maureen R. Goldfarb
  • James W. Kilman, Jr.
  • Steven E. Buller
  • Robert J. Manning
  • John A. Caroselli

Chief Compliance Officer

  • Martin J. Wolin

Price

  • $ 19.93 ( +0 )
    Jun 10, 2022
    Last Close
  • Net Assets
  • $15.3B
    Jul 25, 2022
  • Holding
  • 113
    Jul 25, 2022
    More

  • 52-Week High/Low
  • $24.74 - $19.2
  • Turnover
  • 20%
  • Expense Ratio
  • 1.06%

Company Name

Holding

Roche Holding AG 3.38 %
Novo Nordisk A/S 3.29 %
Nestle SA 3.15 %
Linde PLC 2.81 %
Schneider Electric SE 2.39 %
LVMH Moet Hennessy Louis Vuitton SE 2.15 %
Hitachi Ltd 1.7 %
British American Tobacco PLC 1.54 %
UBS Group AG 1.53 %
AIA Group Ltd 1.48 %
More 1.48 %

Documents

Prospectus

Annual Reports

Performance

YTD

-

3 Year

13.11%

5 Year

10.91%

Best

32.3%

2003

Worst

-42.58%

2008

Alpha

EARSX S&P 500

Chart +